# NIH Reporter #5P50CA097190-20

Project 3: Determining biomarkers for responsiveness to immunotherapy targeting LAG3/PD1 in HNSCC

**Recipient:** University of Pittsburgh at Pittsburgh

**Award Amount:** $302,039.00
**Ceiling:** $302,039.00

**Awarded:** September 04, 2026

**Identifier:** 5P50CA097190-20

Research project focused on identifying biomarkers to predict responsiveness to immunotherapy targeting LAG3 and PD1 in head and neck squamous cell carcinoma, aiming to improve treatment outcomes.

### Description

This project aims to understand the mechanisms of immune response and resistance in head and neck squamous cell carcinoma (HNSCC) related to immunotherapy targeting LAG3 and PD1, with the goal of improving patient outcomes through biomarker discovery and novel therapeutic strategies.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11404948)